PRRT2 and infection: In this study, we subsequently used PKC inhibitor Bisindolylmaleimide I in all infection groups to further evaluate PKC’s role in barrier function, and the results support our hypothesis that inhibition of PKC was involved in SpvB-mediated intestinal barrier dysfunction.